Birdwatch Archive

Birdwatch Note

2023-07-22 02:07:06 UTC - NOT_MISLEADING

"Ivermectin is an FDA-approved broad-spectrum antiparasitic agent with demonstrated antiviral activity against a number of DNA and RNA viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539925/#:~:text=Ivermectin%20is%20an%20FDA%2Dapproved,SARS%2DCoV%2D2).

Written by 54E3AF42AE99425CAE55300ECC8A8F49B1B84DE497D10BA799F2F986A0DD4F4D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1682556811612680193

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1682572949805494277
  • noteId - 1682572949805494277
  • participantId -
  • noteAuthorParticipantId - 54E3AF42AE99425CAE55300ECC8A8F49B1B84DE497D10BA799F2F986A0DD4F4D Participant Details
  • createdAtMillis - 1689991626584
  • tweetId - 1682556811612680193
  • classification - NOT_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 1
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • "Ivermectin is an FDA-approved broad-spectrum antiparasitic agent with demonstrated antiviral activity against a number of DNA and RNA viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539925/#:~:text=Ivermectin%20is%20an%20FDA%2Dapproved,SARS%2DCoV%2D2).

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-07-22 02:07:06 UTC
(1689991626584)
1969-12-31 23:59:59 UTC
(-1)
2023-07-23 04:10:19 UTC
(1690085419289)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-07-22 18:45:32 -0500 Rating Details
2023-07-22 18:41:58 -0500 Rating Details
2023-07-22 18:38:47 -0500 Rating Details
2023-07-22 18:31:32 -0500 Rating Details
2023-07-22 18:30:46 -0500 Rating Details
2023-07-22 17:45:05 -0500 Rating Details
2023-07-22 17:36:44 -0500 Rating Details
2023-07-22 17:26:48 -0500 Rating Details
2023-07-22 17:11:45 -0500 Rating Details
2023-07-22 16:55:52 -0500 Rating Details
2023-07-22 16:44:11 -0500 Rating Details
2023-07-22 16:15:52 -0500 Rating Details
2023-07-22 15:59:56 -0500 Rating Details
2023-07-22 15:59:17 -0500 Rating Details
2023-07-22 15:58:07 -0500 Rating Details
2023-07-22 15:51:32 -0500 Rating Details
2023-07-22 15:49:53 -0500 Rating Details
2023-07-22 15:31:42 -0500 Rating Details
2023-07-22 15:27:46 -0500 Rating Details
2023-07-22 15:22:06 -0500 Rating Details
2023-07-22 15:17:09 -0500 Rating Details
2023-07-22 15:10:49 -0500 Rating Details
2023-07-22 14:43:57 -0500 Rating Details
2023-07-22 14:11:07 -0500 Rating Details
2023-07-22 14:06:07 -0500 Rating Details
2023-07-22 13:42:16 -0500 Rating Details
2023-07-22 13:39:02 -0500 Rating Details
2023-07-22 13:36:10 -0500 Rating Details
2023-07-22 13:15:04 -0500 Rating Details
2023-07-22 13:02:11 -0500 Rating Details
2023-07-22 12:52:43 -0500 Rating Details
2023-07-22 12:45:40 -0500 Rating Details
2023-07-22 12:37:34 -0500 Rating Details
2023-07-22 12:35:20 -0500 Rating Details
2023-07-22 12:27:21 -0500 Rating Details
2023-07-22 12:12:32 -0500 Rating Details
2023-07-22 11:57:25 -0500 Rating Details
2023-07-22 11:49:46 -0500 Rating Details
2023-07-22 11:46:08 -0500 Rating Details
2023-07-22 11:11:07 -0500 Rating Details
2023-07-22 11:04:22 -0500 Rating Details
2023-07-22 10:40:36 -0500 Rating Details
2023-07-22 10:39:27 -0500 Rating Details
2023-07-22 10:12:13 -0500 Rating Details
2023-07-22 10:03:08 -0500 Rating Details
2023-07-22 09:58:17 -0500 Rating Details
2023-07-22 09:34:20 -0500 Rating Details
2023-07-22 09:33:48 -0500 Rating Details
2023-07-22 09:20:43 -0500 Rating Details
2023-07-22 09:03:37 -0500 Rating Details
2023-07-22 08:03:28 -0500 Rating Details
2023-07-22 07:52:19 -0500 Rating Details
2023-07-22 07:48:13 -0500 Rating Details
2023-07-22 07:25:17 -0500 Rating Details
2023-07-22 07:08:37 -0500 Rating Details
2023-07-22 06:38:07 -0500 Rating Details
2023-07-22 06:30:27 -0500 Rating Details
2023-07-22 06:28:23 -0500 Rating Details
2023-07-22 06:25:06 -0500 Rating Details
2023-07-22 05:58:30 -0500 Rating Details
2023-07-22 05:33:25 -0500 Rating Details
2023-07-22 05:07:12 -0500 Rating Details
2023-07-22 05:05:28 -0500 Rating Details
2023-07-22 04:22:55 -0500 Rating Details
2023-07-22 03:35:23 -0500 Rating Details
2023-07-22 03:28:43 -0500 Rating Details
2023-07-22 03:21:11 -0500 Rating Details
2023-07-22 03:20:16 -0500 Rating Details
2023-07-22 01:58:44 -0500 Rating Details
2023-07-22 01:31:06 -0500 Rating Details
2023-07-22 00:34:50 -0500 Rating Details
2023-07-21 23:42:51 -0500 Rating Details
2023-07-21 23:42:27 -0500 Rating Details
2023-07-21 23:26:34 -0500 Rating Details
2023-07-21 23:21:05 -0500 Rating Details
2023-07-21 23:07:31 -0500 Rating Details
2023-07-21 22:56:02 -0500 Rating Details
2023-07-21 22:37:50 -0500 Rating Details
2023-07-21 22:11:20 -0500 Rating Details
2023-07-21 22:07:02 -0500 Rating Details
2023-07-21 22:05:10 -0500 Rating Details
2023-07-21 22:01:47 -0500 Rating Details
2023-07-21 22:00:45 -0500 Rating Details
2023-07-21 21:58:12 -0500 Rating Details
2023-07-21 21:52:09 -0500 Rating Details
2023-07-21 21:34:02 -0500 Rating Details
2023-07-21 21:28:43 -0500 Rating Details
2023-07-21 21:27:23 -0500 Rating Details
2023-07-21 21:24:44 -0500 Rating Details
2023-07-21 21:24:04 -0500 Rating Details
2023-07-21 21:16:07 -0500 Rating Details
2023-07-21 21:15:17 -0500 Rating Details
2023-07-21 21:11:20 -0500 Rating Details
2023-07-23 19:06:37 -0500 Rating Details
2023-07-23 18:01:52 -0500 Rating Details
2023-07-23 16:05:49 -0500 Rating Details
2023-07-23 13:17:06 -0500 Rating Details
2023-07-23 13:14:43 -0500 Rating Details
2023-07-23 12:36:40 -0500 Rating Details
2023-07-23 12:22:50 -0500 Rating Details
2023-07-23 08:26:58 -0500 Rating Details
2023-07-23 08:23:07 -0500 Rating Details
2023-07-23 07:51:05 -0500 Rating Details
2023-07-23 07:38:55 -0500 Rating Details
2023-07-23 07:29:34 -0500 Rating Details
2023-07-23 07:05:10 -0500 Rating Details
2023-07-23 06:18:39 -0500 Rating Details
2023-07-23 04:18:00 -0500 Rating Details
2023-07-23 01:31:49 -0500 Rating Details
2023-07-23 01:17:44 -0500 Rating Details
2023-07-23 01:14:11 -0500 Rating Details
2023-07-23 01:03:32 -0500 Rating Details
2023-07-23 00:57:27 -0500 Rating Details
2023-07-22 21:54:59 -0500 Rating Details
2023-07-22 21:15:37 -0500 Rating Details
2023-07-22 21:06:10 -0500 Rating Details
2023-07-22 20:48:42 -0500 Rating Details
2023-07-22 20:45:10 -0500 Rating Details
2023-07-22 20:21:53 -0500 Rating Details
2023-07-22 20:00:55 -0500 Rating Details
2023-07-22 19:53:41 -0500 Rating Details
2023-07-22 19:51:38 -0500 Rating Details
2023-07-24 04:14:35 -0500 Rating Details
2023-07-23 22:26:06 -0500 Rating Details
2023-07-23 22:25:15 -0500 Rating Details
2023-07-23 20:51:43 -0500 Rating Details
2023-07-27 14:24:32 -0500 Rating Details
2023-07-29 09:46:34 -0500 Rating Details
2023-07-30 17:51:14 -0500 Rating Details
2023-07-30 05:28:02 -0500 Rating Details
2023-07-31 02:46:51 -0500 Rating Details
2023-08-01 02:36:53 -0500 Rating Details
2024-01-14 04:38:31 -0600 Rating Details